174 related articles for article (PubMed ID: 6408114)
1. Antitumor activity of clomiphene analogs in vitro: relationship to affinity for the estrogen receptor and another high affinity antiestrogen-binding site.
Murphy LC; Sutherland RL
J Clin Endocrinol Metab; 1983 Aug; 57(2):373-9. PubMed ID: 6408114
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro.
Murphy LC; Sutherland RL
Endocrinology; 1985 Mar; 116(3):1071-8. PubMed ID: 3971898
[TBL] [Abstract][Full Text] [Related]
3. Geometric isomers of substituted triphenylethylenes and antiestrogen action.
Jordan VC; Haldemann B; Allen KE
Endocrinology; 1981 Apr; 108(4):1353-61. PubMed ID: 6781873
[TBL] [Abstract][Full Text] [Related]
4. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
Watts CK; Sutherland RL
Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
[TBL] [Abstract][Full Text] [Related]
5. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
Lippman M; Bolan G; Huff K
Cancer Treat Rep; 1976 Oct; 60(10):1421-9. PubMed ID: 1035504
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the estradiol-induced growth of cultured human breast cancer cells by the anti-estrogens tamoxifen, desmethyl-tamoxifen, 4-hydroxy-tamoxifen and enclomiphene.
Marth C; Daxenbichler G; Buehring GC; Hofstädter F; Dapunt O
Biochem Pharmacol; 1984 Dec; 33(24):3951-6. PubMed ID: 6439216
[TBL] [Abstract][Full Text] [Related]
7. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.
Reddel RR; Murphy LC; Sutherland RL
Cancer Res; 1983 Oct; 43(10):4618-24. PubMed ID: 6883318
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of the estrogen receptor's positive cooperative [3H]estradiol binding by the antagonist, clomiphene.
Sasson S; Notides AC
J Biol Chem; 1982 Oct; 257(19):11540-5. PubMed ID: 7118895
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of growth inhibition by nonsteroidal antioestrogens in human breast cancer cells.
Sutherland RL; Watts CK; Hall RE; Ruenitz PC
J Steroid Biochem; 1987; 27(4-6):891-7. PubMed ID: 3695509
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and chemopreventive effects of a clomiphene analog, MDL 103,323, in mammary carcinoma.
Bitonti AJ; Baumann RJ; Bush TL; Cashman EA; Wright CL; Prakash NJ
Anticancer Res; 1996; 16(5A):2553-7. PubMed ID: 8917350
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
Burke PJ; Kalet BT; Koch TH
J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic and antiestrogenic effects of enclomiphene and zuclomiphene on gonadotropin secretion by ovine pituitary cells in culture.
Huang ES; Miller WL
Endocrinology; 1983 Feb; 112(2):442-8. PubMed ID: 6401242
[TBL] [Abstract][Full Text] [Related]
15. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
[TBL] [Abstract][Full Text] [Related]
16. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
17. Effects of enclomiphene and zuclomiphene on basal and gonadotrophin-stimulated progesterone secretion by isolated subpopulations of small and large ovine luteal cells.
Opsahl MS; Fitz TA; Rexroad CE; Fritz MA
Hum Reprod; 1996 Jun; 11(6):1250-5. PubMed ID: 8671435
[TBL] [Abstract][Full Text] [Related]
18. Differential responses of estrogen target tissues in rats including bone to clomiphene, enclomiphene, and zuclomiphene.
Turner RT; Evans GL; Sluka JP; Adrian MD; Bryant HU; Turner CH; Sato M
Endocrinology; 1998 Sep; 139(9):3712-20. PubMed ID: 9724022
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
Murphy CS; Parker CJ; McCague R; Jordan VC
Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
[TBL] [Abstract][Full Text] [Related]
20. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
Lopes MC; Tavares MC; Vale MG; Carvalho AP
J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]